Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating diseases with a VEGF antagonist

Methods of treating diseases with a VEGF antagonist

US Patent 7531172 · Granted May 12, 2009

Estimated economic value: $8,455,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Compositions and methods for using bispecific antibodies to bind complement and 2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
EGFR x CD28 multispecific antibodies2025
Genetically modified mice and engraftment2025
VEGF antagonist formulations suitable for intravitreal administration2025
Modified urokinase-type plasminogen activator polypeptides and methods of use2025
Immunoglobulin proteins that bind to NPR1 agonists2025
Use of a VEGF antagonist to treat angiogenic eye disorders2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
High affinity human antibodies to human IL-4 receptor2024